ASK REDCHAT ANYTHING ABOUT JOURNEY MEDICAL CORPORATION
Journey Medical Corporation (NASDAQ: DERM)
Listen to this Section
$5.96
-0.2600
(
-4.18% )
50.9K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Emrosi™ (Formerly DFD-29)DetailsPapulopustular rosacea |
Approved |
Market Data
|
| Open |
$5.96 |
| Previous Close |
$6.22 |
| Volume |
50.9K |
| Market Cap |
$166.86M |
| Day Range |
$5.96 - $6.23 |
| 52 Week Range |
$4.31 - $9.56 |
| Shares Outstanding |
27.53M |
| Change % |
-4.18% |
| Net Change |
▼ -0.2600 |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2021 |
| Country | United States |
| Underwriter | B. Riley Securities, Roth Capital, more |
Insider Ownership Transactions
Total Amount Purchased:
135,313.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-08-01 |
Sale |
-9324.00 |
Benesch Joseph |
| 2024-07-23 |
Sale |
-4055.00 |
Benesch Joseph |
| 2024-07-23 |
Sale |
-30000.00 |
Pearce Michael Cooper |
| 2024-07-10 |
Sale |
-9728.00 |
Smith Justin Adam |
| 2024-07-10 |
Sale |
-9728.00 |
ROSENWALD LINDSAY A MD |
| 2024-07-10 |
Sale |
-9728.00 |
Toledano Miranda Jayne |
| 2024-07-10 |
Sale |
-9728.00 |
Herskowitz Neil |
| 2024-05-31 |
Sale |
-50000.00 |
Fortress Biotech, Inc. |
| 2024-03-27 |
Buy |
10000.00 |
ROSENWALD LINDSAY A MD |
| 2024-03-25 |
Buy |
30000.00 |
Smith Justin Adam |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 10-q |
Quarterly Reports |
88 |
Nov 12, 2025 |
| 8-k |
8K-related |
14 |
Nov 12, 2025 |
| 8-k |
8K-related |
12 |
Sep 26, 2025 |
| 8-k |
8K-related |
15 |
Aug 28, 2025 |
| 4 |
Insider transactions |
1 |
Aug 26, 2025 |
| 10-q |
Quarterly Reports |
86 |
Aug 12, 2025 |
| 8-k |
8K-related |
14 |
Aug 12, 2025 |
| 4 |
Insider transactions |
1 |
Aug 07, 2025 |
| 4 |
Insider transactions |
1 |
Aug 07, 2025 |
| 4 |
Insider transactions |
1 |
Aug 07, 2025 |